Padlas-L 40mg/240mg Tablet
Marketer
Aden Healthcare
Salt Composition
Artemether (40mg) + Lumefantrine (240mg)
Overview Padlas-L 40mg/240mg Tablet
Malarone-L 40mg/240mg tablets treat malaria in adults and children. This combination antimalarial medication effectively combats the malaria parasite, halting infection progression. However, it's unsuitable for malaria prevention or severe cases affecting vital organs (brain, lungs, kidneys). Optimal absorption requires ingestion with food. Always adhere strictly to your physician's prescribed dosage and duration; exceeding the recommended amount can be detrimental. Complete the entire course for thorough eradication of the infection. Common side effects may include headache, decreased appetite, fatigue, arthralgia, myalgia, and dizziness. Report persistent or intensifying side effects to your doctor. Inform your doctor of all other medications you're using before commencing treatment. Pregnant or breastfeeding individuals should only use this medication under strict medical supervision due to potential harm to the fetus or infant.
Uses of Padlas-L 40mg/240mg Tablet
Managing Malaria Infections
Major Benefits of Padlas-L 40mg/240mg Tablet:
Follow your physician's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Padlas-L 40mg/240mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Padlas-L 40mg/240mg Tablet:
- Headache
- Loss of appetite
- Dizziness
- Weakness
- Joint pain
- Muscle pain
How to use Padlas-L 40mg/240mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Padlas-L 40mg/240mg Tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.
How Padlas-L 40mg/240mg Tablet works:
Artemether and lumefantrine, combined in Padlas-L 40mg/240mg tablets, provide effective malaria treatment. Their mechanism involves elevating blood heme concentrations, a process toxic to the malaria parasite, thereby eliminating the infection and halting its progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Padlas-L 40mg/240mg Tablets may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Padlas-L 40mg/240mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of Padlas-L 40mg/240mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Taking Padlas-L 40mg/240mg tablets may cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
For individuals with severe kidney impairment, the use of Padlas-L 40mg/240mg tablets requires careful monitoring. Dosage modification might be necessary; physician consultation is advised. Severe kidney disease does not necessitate a dosage alteration.
LiverCAUTION
For individuals with severe hepatic impairment, the administration of Padlas-L 40mg/240mg tablets requires careful consideration. Dosage modification of Padlas-L 40mg/240mg tablets may be necessary. Physician consultation is advised. However, dosage alteration is generally not recommended for patients with severe liver disease.
What if you forget to take Padlas-L 40mg/240mg Tablet :
Should you forget to take a Padlas-L 40mg/240mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.
Facts to Know About Padlas-L 40mg/240mg Tablet
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Category | Antimalarial medications |
3,018 People bought this recently